Tags

Type your tag names separated by a space and hit enter

A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease.
Eur J Gastroenterol Hepatol 2003; 15(9):1001-4EJ

Abstract

BACKGROUND

Tissue transglutaminase is now recognized as the autoantigen for antiendomysial antibodies. Antibodies to tissue transglutaminase have been proposed as a valuable test for coeliac disease.

OBJECTIVE

To determine the value of antibodies to tissue transglutaminase in the diagnosis of coeliac disease in our outpatient population.

METHODS

Patients who underwent serological tests for coeliac disease during the first 18 months of the tissue transglutaminase antibody assay were retrospectively identified from the regional serology laboratory database. Patients' symptoms were noted, along with serological results and duodenal histology in those patients who underwent duodenal biopsy. RESULTS In total, 586 patients were identified as having been serologically tested for coeliac disease, of whom 92 patients (33 men; mean age 51.7 years) had been followed up with duodenal biopsies. Of these 92 patients, 29 (31%; 14 men; mean age 52.5 years) had histological features of coeliac disease. The 63 patients with normal histology (19 men; mean age 51.8 years) acted as controls. Weight loss was more frequent in coeliac disease patients compared to controls (7 vs 5; P = 0.04) whereas the frequency of anaemia (P = 0.85) and diarrhoea (P = 0.74) did not differ significantly between the two groups. The sensitivity and specificity of tissue transglutaminase antibodies (86%; 84%) were compared to those for antiendomysial antibodies (90%; 98%) and antigliadin antibodies (76%; 79%).

CONCLUSIONS

The diagnostic value of tissue transglutaminase antibodies was intermediate between that of antiendomysial antibodies and antigliadin antibodies. However, duodenal biopsy remains the gold standard diagnostic test for coeliac disease.

Authors+Show Affiliations

Department of Gastroenterology, Belfast City Hospital, Northern Ireland, UK. simon.johnston@bch.n-i.nhs.ukNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Multicenter Study

Language

eng

PubMed ID

12923373

Citation

Johnston, Simon D., et al. "A Comparison of Antibodies to Tissue Transglutaminase With Conventional Serological Tests in the Diagnosis of Coeliac Disease." European Journal of Gastroenterology & Hepatology, vol. 15, no. 9, 2003, pp. 1001-4.
Johnston SD, McMillan SA, Collins JS, et al. A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease. Eur J Gastroenterol Hepatol. 2003;15(9):1001-4.
Johnston, S. D., McMillan, S. A., Collins, J. S., Tham, T. C., McDougall, N. I., & Murphy, P. (2003). A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease. European Journal of Gastroenterology & Hepatology, 15(9), pp. 1001-4.
Johnston SD, et al. A Comparison of Antibodies to Tissue Transglutaminase With Conventional Serological Tests in the Diagnosis of Coeliac Disease. Eur J Gastroenterol Hepatol. 2003;15(9):1001-4. PubMed PMID: 12923373.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease. AU - Johnston,Simon D, AU - McMillan,Stanley A, AU - Collins,John S, AU - Tham,Tony C, AU - McDougall,Neil I, AU - Murphy,Philip, PY - 2003/8/19/pubmed PY - 2003/10/15/medline PY - 2003/8/19/entrez SP - 1001 EP - 4 JF - European journal of gastroenterology & hepatology JO - Eur J Gastroenterol Hepatol VL - 15 IS - 9 N2 - BACKGROUND: Tissue transglutaminase is now recognized as the autoantigen for antiendomysial antibodies. Antibodies to tissue transglutaminase have been proposed as a valuable test for coeliac disease. OBJECTIVE: To determine the value of antibodies to tissue transglutaminase in the diagnosis of coeliac disease in our outpatient population. METHODS: Patients who underwent serological tests for coeliac disease during the first 18 months of the tissue transglutaminase antibody assay were retrospectively identified from the regional serology laboratory database. Patients' symptoms were noted, along with serological results and duodenal histology in those patients who underwent duodenal biopsy. RESULTS In total, 586 patients were identified as having been serologically tested for coeliac disease, of whom 92 patients (33 men; mean age 51.7 years) had been followed up with duodenal biopsies. Of these 92 patients, 29 (31%; 14 men; mean age 52.5 years) had histological features of coeliac disease. The 63 patients with normal histology (19 men; mean age 51.8 years) acted as controls. Weight loss was more frequent in coeliac disease patients compared to controls (7 vs 5; P = 0.04) whereas the frequency of anaemia (P = 0.85) and diarrhoea (P = 0.74) did not differ significantly between the two groups. The sensitivity and specificity of tissue transglutaminase antibodies (86%; 84%) were compared to those for antiendomysial antibodies (90%; 98%) and antigliadin antibodies (76%; 79%). CONCLUSIONS: The diagnostic value of tissue transglutaminase antibodies was intermediate between that of antiendomysial antibodies and antigliadin antibodies. However, duodenal biopsy remains the gold standard diagnostic test for coeliac disease. SN - 0954-691X UR - https://www.unboundmedicine.com/medline/citation/12923373/A_comparison_of_antibodies_to_tissue_transglutaminase_with_conventional_serological_tests_in_the_diagnosis_of_coeliac_disease_ L2 - http://dx.doi.org/10.1097/00042737-200309000-00010 DB - PRIME DP - Unbound Medicine ER -